Free Trial
→ Collect $7k per month from Tesla’s SECRET dividend (From Investors Alley) (Ad)

Surmodics Q2 2023 Earnings Report

Surmodics logo
$34.85 +0.47 (+1.37%)
As of 02/21/2025 04:00 PM Eastern
Earnings HistoryForecast

Surmodics EPS Results

Actual EPS
-$0.40
Consensus EPS
-$0.49
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A

Surmodics Revenue Results

Actual Revenue
$27.20 million
Expected Revenue
$25.99 million
Beat/Miss
Beat by +$1.21 million
YoY Revenue Growth
N/A

Surmodics Announcement Details

Quarter
Q2 2023
Date
4/26/2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Full Screen Slide Deck
Powered by Quartr

Surmodics Earnings Headlines

Q3 Earnings Forecast for Surmodics Issued By Zacks Research
February 22 at 2:26 AM | americanbankingnews.com
Surmodics shareholders approve key proposals at annual meeting
February 11, 2025 | msn.com
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
February 22, 2025 | Investors Alley (Ad)
Surmodics announces clinical use of Pounce XL Thrombectomy System
February 4, 2025 | markets.businessinsider.com
SurModics (SRDX) Receives a Hold from Lake Street
February 1, 2025 | markets.businessinsider.com
Hold Rating on SurModics Amid Revenue Shortfall and Acquisition Uncertainty
January 31, 2025 | markets.businessinsider.com
See More Surmodics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Surmodics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surmodics and other key companies, straight to your email.

About Surmodics

Surmodics (NASDAQ:SRDX), together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

View Surmodics Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles